| 17alpha-ethynylestradiol | increases expression | ISO | RGD:10209 | 6480464 | Ethinyl Estradiol results in increased expression of ATP1B3 mRNA | CTD | PMID:16174780 PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of ATP1B3 mRNA | CTD | PMID:12075121 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:10209 | 6480464 | Ethinyl Estradiol results in increased expression of ATP1B3 mRNA | CTD | PMID:17942748 PMID:16174780 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of ATP1B3 mRNA | CTD | PMID:12075121 more ... |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of ATP1B3 mRNA | CTD | PMID:16174780 more ... |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:10209 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP1B3 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:10209 | 6480464 | Ethinyl Estradiol affects the expression of ATP1B3 mRNA | CTD | PMID:17555576 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | ISO | RGD:733031 | 6480464 | Dihydrotestosterone results in decreased expression of ATP1B3 mRNA | CTD | PMID:16631469 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10209 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP1B3 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10209 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATP1B3 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATP1B3 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10209 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATP1B3 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATP1B3 mRNA | CTD | PMID:16054898 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of ATP1B3 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of ATP1B3 mRNA | CTD | PMID:21346803 |
| 2-methylcholine | affects expression | ISO | RGD:733031 | 6480464 | beta-methylcholine affects the expression of ATP1B3 mRNA | CTD | PMID:21179406 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of ATP1B3 mRNA | CTD | PMID:19162173 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:10209 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of ATP1B3 mRNA | CTD | PMID:18648102 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:733031 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of ATP1B3 mRNA | CTD | PMID:12419474 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ATP1B3 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10209 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of ATP1B3 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:10209 | 6480464 | Benzo(a)pyrene results in increased expression of ATP1B3 mRNA | CTD | PMID:19770486 PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:10209 | 6480464 | Benzo(a)pyrene results in increased expression of ATP1B3 mRNA | CTD | PMID:19770486 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ATP1B3 mRNA | CTD | PMID:12075121 |
| C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of ATP1B3 mRNA | CTD | PMID:19167457 |
| ciglitazone | decreases expression | EXP | | 6480464 | ciglitazone results in decreased expression of ATP1B3 mRNA | CTD | PMID:22193206 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of ATP1B3 mRNA | CTD | PMID:18172885 |
| cocaine | increases expression | ISO | RGD:10209 | 6480464 | Cocaine results in increased expression of ATP1B3 mRNA | CTD | PMID:18355967 |
| cocaine | multiple interactions | ISO | RGD:10209 | 6480464 | FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of ATP1B3 mRNA] | CTD | PMID:18355967 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of ATP1B3 mRNA | CTD | PMID:21266533 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of ATP1B3 mRNA | CTD | PMID:17011747 |
| dimethyl sulfoxide | increases expression | EXP | | 6480464 | Dimethyl Sulfoxide results in increased expression of ATP1B3 mRNA | CTD | PMID:22193206 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of ATP1B3 mRNA | CTD | PMID:21551480 |
| ethanol | affects expression | EXP | | 6480464 | Ethanol affects the expression of ATP1B3 mRNA | CTD | PMID:11772933 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of ATP1B3 mRNA | CTD | PMID:12075121 |
| haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of ATP1B3 mRNA | CTD | PMID:15860345 |
| hydrogen peroxide | affects expression | ISO | RGD:733031 | 6480464 | Hydrogen Peroxide affects the expression of ATP1B3 mRNA | CTD | PMID:21179406 |
| mercury atom | increases expression | EXP | | 6480464 | Mercury results in increased expression of ATP1B3 mRNA | CTD | PMID:22688007 |
| mercury(0) | increases expression | EXP | | 6480464 | Mercury results in increased expression of ATP1B3 mRNA | CTD | PMID:22688007 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases expression | ISO | RGD:733031 | 6480464 | Methylnitronitrosoguanidine results in decreased expression of ATP1B3 mRNA | CTD | PMID:12634122 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of ATP1B3 mRNA | CTD | PMID:11323195 |
| nickel sulfate | increases expression | ISO | RGD:733031 | 6480464 | nickel sulfate results in increased expression of ATP1B3 mRNA | CTD | PMID:16780908 |
| nickel sulfate | decreases expression | ISO | RGD:733031 | 6480464 | nickel sulfate results in decreased expression of ATP1B3 mRNA | CTD | PMID:18651567 |
| paracetamol | affects expression | ISO | RGD:10209 | 6480464 | Acetaminophen affects the expression of ATP1B3 mRNA | CTD | PMID:17562736 |
| quercetin | increases expression | ISO | RGD:733031 | 6480464 | Quercetin results in increased expression of ATP1B3 mRNA | CTD | PMID:21632981 |
| resveratrol | decreases expression | ISO | RGD:10209 | 6480464 | resveratrol results in decreased expression of ATP1B3 mRNA | CTD | PMID:22610192 |
| sodium fluoride | decreases expression | ISO | RGD:10209 | 6480464 | Sodium Fluoride results in decreased expression of ATP1B3 mRNA | CTD | PMID:21340527 |
| trans-resveratrol | decreases expression | ISO | RGD:10209 | 6480464 | resveratrol results in decreased expression of ATP1B3 mRNA | CTD | PMID:22610192 |
| valproic acid | increases expression | ISO | RGD:733031 | 6480464 | Valproic Acid results in increased expression of ATP1B3 mRNA | CTD | PMID:19101580 |